Alfred Altomari - 09 Nov 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC

Role
Chief Executive Officer, Director
Signature
/s/ Al Altomari
Issuer symbol
N/A
Transactions as of
09 Nov 2022
Net transactions value
$0
Form type
4
Filing time
14 Nov 2022, 15:34:58 UTC
Previous filing
29 Aug 2022
Next filing
15 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Nov 2022 Common Stock 30,000 $0.2000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 9, 2022. 25% of the shares subject to the stock option vest on November 9, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on November 9, 2026.